Data Providers · Truveta
Partnered with Truveta (via Truveta Live Link) to securely link its continuous glucose monitoring (CGM) data with longitudinal EHR records for 200,000+ patients, enabling research into kidney disease progression, risk stratification, and real-world CGM therapy effectiveness
Truveta is a real-world-data company owned by a consortium of major US health systems, supplying daily-updated de-identified EHR data and a genomic-linkage research program.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Source
Published by Truveta on its own site — read the original case study on truveta.com ↗
More like this
Related use cases
- 01Compared its EKOS Endovascular System to Inari Medical's FlowTriever for pulmonary embolism treatment using Truveta Data, finding a higher bleeding risk with the competitor device; the "REAL-PE" study was published and presented within 5 months, versus the years/millions an RCT would have required
- 02Used Truveta Data to build the TREAT-AHF heart-failure registry (~165,000 acute decompensated heart failure patient journeys, ~3x the ADHERE registry), validating its decongestion device and optimizing clinical trial design/enrollment predictions
- 03Used Truveta Data to compare hemodialysis catheter designs across multiple health systems, evaluating infection risks and usage trends to guide product safety and development
- 04Analyzed real-world incidence and prevalence of arrhythmias among epilepsy patients to investigate potential cardiac risks associated with anti-seizure medications
- 05Evolved its commercial, marketing and customer-engagement strategy using Clarivate real-world data and analytics.
- 06Used Clarivate/Cortellis IP and business support to advance a blood test for early ovarian cancer detection toward commercialization.